PSG Mentored Clinical Research Award (MCRA)

PSG Mentored Clinical Research Award (MCRA) is sponsored by Parkinson Study Group (PSG). This grant supports patient-oriented clinical research in Parkinson's disease (PD) or other parkinsonian disorders.

Mentored Clinical Research Award (MCRA) - Parkinson Study Group PSG Mentored Clinical Research Award (MCRA) The mission of the Parkinson Study Group is to advance knowledge about the cause(s), pathogenesis and clinical impact of Parkinson disease and related disorders and to develop and implement scientific strategies to examine promising therapeutic interventions.

The Mentored Clinical Research Award is funded by grants from the Parkinson’s Foundation to the Parkinson Study Group (PSG). The purpose of this grant is to support patient-oriented clinical research in Parkinson’s disease (PD) or other parkinsonian disorders in order to address the unmet needs of people living with these conditions.

The research plan should entail patient-oriented research in PD or other parkinsonian disorders, and address unmet needs of people living with these conditions. The research findings should have the potential for broad application among the PD/parkinsonism community. The work proposed should have potential to lead to advances in clinically relevant treatment options.

The proposal should be hypothesis driven and carry an appropriate data analysis plan. The scope of work should be achievable within an 18-month funding period and appropriate for the budget of the award. The project should include a clearly described mentorship plan.

Applications are eligible only within the US. Award Details for Grant Cycle 2026-2027 Application Portal Opens: June 22, 2026 Application Deadline: September 9, 2026 Award Notification: October 26, 2026 Project Period: January 1, 2027 – June 30, 2028 Up to $75,000 total costs for the entire project period.

The award budget must include all project-related expenses , including but not limited to personnel effort/salary support, fringe benefits, supplies, participant costs, travel, and other direct project expenses. No additional funds will be provided beyond the total award amount.

Any early career investigator (i.e., MD or PhD within 5 years of completing training) seeking to become an independent researcher in the field of PD, or Any established investigator beginning a new line of research for which preliminary clinical data are needed. Cover letter stating intent and clearly stating if submission is a revision of a proposal previously submitted.

Applications that have been revised and are being resubmitted should include a brief Introduction (no more than 1 page) addressing the response to the prior reviewers’ comments. Indicate actual changes in the revised application using some convention, such as bold, italic or highlighting text, unless the changes are so extensive that this is not practical.

In the latter case, please indicate this clearly in the introduction to the revised application. Abbreviated NIH format proposal (maximum of 6 pages) to include a title, the specific aims of the study (~ 1 page), background and significance (~ 1 page), research design and methods (including pilot study data, a protocol synopsis, and schedule of activities if relevant, ~ 3 pages), and expected outcomes and impact (~ 0. 5 – 1 page).

References should be included but are not counted toward the six-page limit. The title may be placed at the top of the first page; a separate title page is not necessary. Clinical research proposals need not be pre-approved by institutional IRB, but should include a Human Subjects section that addresses concerns pertaining to risk, benefit and consent (not included in the 6 page limit).

A Budget and brief Budget Justification are required for all funds requested. No indirect costs will be funded. A letter of support from the PSG Mentor that you intend to work with endorsing the project.

Applications will be reviewed by the PSG Mentorship Committee according to the criteria and timelines described. Successful applicants will be required to submit a written summary of progress at six months and at one year after funding. The awardee will be required to attend a future PSG annual meeting in order to present the results of their research, with meeting expenses to be supported by the PSG separate from the grant award.

You must be registered and logged in to access this form. The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.

Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage {vendor_count} vendors The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors